My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions.

    Keijser S, Missotten GS, Bonfrer JM, de Wolff-Rouendaal D, Jager MJ, de Keizer RJ.

    Br J Ophthalmol. 2006 Feb;90(2):213-7.PMID: 16424536 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differential immunoreactivity of melanocytic lesions of the conjunctiva.

    Sharara NA, Alexander RA, Luthert PJ, Hungerford JL, Cree IA.

    Histopathology. 2001 Oct;39(4):426-31.PMID: 11683945 [PubMed - indexed for MEDLINE]Related articles

    3.

    Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.

    Böni R, Burg G, Doguoglu A, Ilg EC, Schäfer BW, Müller B, Heizmann CW.

    Br J Dermatol. 1997 Jul;137(1):39-43.PMID: 9274623 [PubMed - indexed for MEDLINE]Related articles

    4.

    Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.

    Steuhl KP, Rohrbach JM, Knorr M, Thiel HJ.

    Ophthalmology. 1993 Feb;100(2):208-15.PMID: 8437829 [PubMed - indexed for MEDLINE]Related articles

    5.

    Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.

    Heegaard S, Jensen OA, Prause JU.

    Melanoma Res. 2000 Aug;10(4):350-4.PMID: 10985669 [PubMed - indexed for MEDLINE]Related articles

    6.

    Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma.

    Böni R, Heizmann CW, Doguoglu A, Ilg EC, Schäfer BW, Dummer R, Burg G.

    J Cutan Pathol. 1997 Feb;24(2):76-80.PMID: 9162739 [PubMed - indexed for MEDLINE]Related articles

    7.

    In vivo confocal microscopy of pigmented conjunctival tumors.

    Messmer EM, Mackert MJ, Zapp DM, Kampik A.

    Graefes Arch Clin Exp Ophthalmol. 2006 Nov;244(11):1437-45. Epub 2006 Apr 6.PMID: 16598465 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva]

    Hitzer S, Bialasiewicz AA, Richard G.

    Klin Monbl Augenheilkd. 1998 Oct;213(4):230-7. German. PMID: 9848068 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pigmented conjunctival and scleral lesions.

    Liesegang TJ.

    Mayo Clin Proc. 1994 Feb;69(2):151-61. Review.PMID: 8309267 [PubMed - indexed for MEDLINE]Related articles

    10.

    The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).

    Clarkson KS, Sturdgess IC, Molyneux AJ.

    J Clin Pathol. 2001 Mar;54(3):196-200.PMID: 11253130 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.

    Iwamoto S, Burrows RC, Grossniklaus HE, Orcutt J, Kalina RE, Boehm M, Bothwell MA, Schmidt R.

    Arch Ophthalmol. 2002 Dec;120(12):1625-9.PMID: 12470134 [PubMed - indexed for MEDLINE]Related articles

    12.

    Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.

    Seregard S, Oskarsson M, Spângberg B.

    Exp Eye Res. 1999 Dec;69(6):671-6.PMID: 10620396 [PubMed - indexed for MEDLINE]Related articles

    13.

    Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.

    Fröhlich E, Mack AF, Garbe C, Klessen C.

    Br J Dermatol. 2005 Dec;153(6):1159-65.PMID: 16307652 [PubMed - indexed for MEDLINE]Related articles

    14.

    Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.

    Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.

    J Pathol. 2001 Jun;194(2):194-200.PMID: 11400148 [PubMed - indexed for MEDLINE]Related articles

    15.

    Conjunctival amelanotic malignant melanoma arising in primary acquired melanosis sine pigmento.

    Jay V, Font RL.

    Ophthalmology. 1998 Jan;105(1):191-4.PMID: 9442798 [PubMed - indexed for MEDLINE]Related articles

    16.

    Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.

    Ben-Izhak O, Stark P, Levy R, Bergman R, Lichtig C.

    Am J Dermatopathol. 1994 Jun;16(3):241-6.PMID: 7524376 [PubMed - indexed for MEDLINE]Related articles

    17.

    Conjunctival melanomas.

    Eng AM, Rosner M.

    Int J Dermatol. 1995 May;34(5):349-53.PMID: 7607797 [PubMed - indexed for MEDLINE]Related articles

    18.

    Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.

    Sundram U, Harvell JD, Rouse RV, Natkunam Y.

    Mod Pathol. 2003 Aug;16(8):802-10.PMID: 12920225 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Ocular melanomas and melanocytic lesions of the eye.

    Grin JM, Grant-Kels JM, Grin CM, Berke A, Kels BD.

    J Am Acad Dermatol. 1998 May;38(5 Pt 1):716-30. Review.PMID: 9591817 [PubMed - indexed for MEDLINE]Related articles

    20.

    Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.

    Nonaka D, Chiriboga L, Rubin BP.

    J Cutan Pathol. 2008 Nov;35(11):1014-9. Epub 2008 Jun 10.PMID: 18547346 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity